| Product Code: ETC13245754 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Bursitis Treatment Market was valued at USD 1.3 Billion in 2024 and is expected to reach USD 2.1 Billion by 2031, growing at a compound annual growth rate of 7.27% during the forecast period (2025-2031).
The global bursitis treatment market is experiencing steady growth due to the increasing prevalence of musculoskeletal disorders and sports injuries worldwide. Bursitis is a common condition characterized by inflammation of the bursae, fluid-filled sacs that cushion the joints. The market is driven by the rising geriatric population, growing awareness about treatment options, and advancements in healthcare infrastructure. Nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, physical therapy, and surgical interventions are the primary treatment modalities employed. North America holds a significant market share due to the high incidence of bursitis cases in the region, while Asia Pacific is expected to witness rapid growth attributed to improving healthcare facilities and rising disposable income. Key players in the global bursitis treatment market include Pfizer Inc., Merck & Co., Inc., and Novartis AG, among others.
The Global Bursitis Treatment Market is witnessing growth due to the increasing prevalence of bursitis, primarily driven by the aging population and rising sports-related injuries. Key trends include the growing adoption of minimally invasive procedures, advancements in drug therapies, and the development of innovative treatment options such as regenerative medicine. Opportunities in the market lie in the expansion of treatment options beyond traditional methods, the introduction of novel drug formulations, and the focus on personalized medicine approaches. Additionally, the rise in healthcare expenditure, improving healthcare infrastructure in emerging markets, and the increasing awareness about bursitis and its treatment options among patients are expected to further drive market growth in the coming years.
The Global Bursitis Treatment Market faces several challenges, including limited awareness among individuals about bursitis, leading to underdiagnosis and undertreatment of the condition. Additionally, the lack of specific diagnostic tests for bursitis poses a challenge in accurately identifying and differentiating it from other musculoskeletal disorders. Treatment options for bursitis are often focused on symptomatic relief through rest, ice, and anti-inflammatory medications, with limited effective long-term solutions available. Furthermore, the market also encounters issues related to the high cost of advanced treatment options such as corticosteroid injections or physical therapy, which may hinder access for some patients. Overall, addressing these challenges requires advancements in diagnostic capabilities, increased awareness among healthcare professionals and patients, as well as the development of more effective and affordable treatment options for bursitis.
The Global Bursitis Treatment Market is primarily driven by the increasing prevalence of musculoskeletal disorders and sports-related injuries, leading to a higher demand for effective treatment options. The rising geriatric population worldwide, who are more prone to developing bursitis, is also a significant driver for market growth. Additionally, the advancements in medical technologies and treatment modalities, such as minimally invasive procedures and innovative pharmaceuticals, are contributing to the expansion of the bursitis treatment market. Moreover, the growing awareness about the importance of early diagnosis and prompt treatment of bursitis among healthcare professionals and patients is further fueling market growth. Overall, these factors are driving the market towards a positive trajectory with opportunities for further development and innovation in bursitis treatment options.
Government policies related to the Global Bursitis Treatment Market primarily focus on regulating the manufacturing, marketing, and distribution of bursitis treatment drugs and medical devices to ensure safety, efficacy, and quality standards are met. These policies often involve stringent approval processes by regulatory bodies such as the FDA in the United States and the EMA in Europe, requiring companies to demonstrate the effectiveness and safety of their products before they can be marketed. Additionally, government healthcare policies may influence access to bursitis treatments through reimbursement schemes or healthcare programs, impacting market demand and pricing dynamics. Overall, government regulations play a crucial role in shaping the landscape of the Global Bursitis Treatment Market by safeguarding patient interests and promoting innovation in the development of new treatment options.
The Global Bursitis Treatment Market is projected to experience steady growth in the coming years due to the increasing prevalence of bursitis, particularly among the aging population. Technological advancements in diagnostic tools and treatment options are expected to drive market expansion as healthcare providers seek more effective and minimally invasive solutions. Additionally, the rising awareness about the importance of early diagnosis and treatment of bursitis is likely to further boost market growth. However, challenges such as high treatment costs and limited access to healthcare in certain regions may impede market progress. Overall, the Global Bursitis Treatment Market is poised for growth, with opportunities for innovation and market penetration in emerging economies presenting promising avenues for market players.
In the global bursitis treatment market, North America and Europe are expected to dominate due to the high prevalence of bursitis cases, advanced healthcare infrastructure, and higher healthcare spending. Asia Pacific is anticipated to witness significant growth driven by the rising awareness about bursitis, improving healthcare facilities, and increasing disposable income. The Middle East and Africa region is projected to show moderate growth, primarily due to the growing geriatric population and expanding healthcare sector. Latin America is also expected to experience steady growth in the bursitis treatment market, driven by improving access to healthcare services and a growing focus on preventive healthcare measures. Overall, the global bursitis treatment market is likely to see a steady increase in demand across all regions in the forecast period.
Global Bursitis Treatment Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Bursitis Treatment Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Bursitis Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Global Bursitis Treatment Market - Industry Life Cycle |
3.4 Global Bursitis Treatment Market - Porter's Five Forces |
3.5 Global Bursitis Treatment Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Bursitis Treatment Market Revenues & Volume Share, By Devices, 2021 & 2031F |
3.7 Global Bursitis Treatment Market Revenues & Volume Share, By Drug, 2021 & 2031F |
3.8 Global Bursitis Treatment Market Revenues & Volume Share, By Delivery Type, 2021 & 2031F |
3.9 Global Bursitis Treatment Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 Global Bursitis Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Bursitis Treatment Market Trends |
6 Global Bursitis Treatment Market, 2021 - 2031 |
6.1 Global Bursitis Treatment Market, Revenues & Volume, By Devices, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Bursitis Treatment Market, Revenues & Volume, By Surgical Device, 2021 - 2031 |
6.1.3 Global Bursitis Treatment Market, Revenues & Volume, By Diagnostics & Monitoring Devices, 2021 - 2031 |
6.1.4 Global Bursitis Treatment Market, Revenues & Volume, By Vision Care, 2021 - 2031 |
6.2 Global Bursitis Treatment Market, Revenues & Volume, By Drug, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Bursitis Treatment Market, Revenues & Volume, By Glaucoma Drugs, 2021 - 2031 |
6.2.3 Global Bursitis Treatment Market, Revenues & Volume, By Retinal Disorder Drugs, 2021 - 2031 |
6.2.4 Global Bursitis Treatment Market, Revenues & Volume, By Dry Eye Drugs, 2021 - 2031 |
6.2.5 Global Bursitis Treatment Market, Revenues & Volume, By Allergic Conjunctivitis and Inflammation Drugs, 2021 - 2031 |
6.3 Global Bursitis Treatment Market, Revenues & Volume, By Delivery Type, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Bursitis Treatment Market, Revenues & Volume, By Capsules & Tablets, 2021 - 2031 |
6.3.3 Global Bursitis Treatment Market, Revenues & Volume, By Gels, 2021 - 2031 |
6.3.4 Global Bursitis Treatment Market, Revenues & Volume, By Eye Drops, 2021 - 2031 |
6.3.5 Global Bursitis Treatment Market, Revenues & Volume, By Eye Ointment, 2021 - 2031 |
6.3.6 Global Bursitis Treatment Market, Revenues & Volume, By Eye Solutions, 2021 - 2031 |
6.4 Global Bursitis Treatment Market, Revenues & Volume, By End Use, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Bursitis Treatment Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.3 Global Bursitis Treatment Market, Revenues & Volume, By Diagnostic Centres, 2021 - 2031 |
7 North America Bursitis Treatment Market, Overview & Analysis |
7.1 North America Bursitis Treatment Market Revenues & Volume, 2021 - 2031 |
7.2 North America Bursitis Treatment Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Bursitis Treatment Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Bursitis Treatment Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Bursitis Treatment Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Bursitis Treatment Market, Revenues & Volume, By Devices, 2021 - 2031 |
7.4 North America Bursitis Treatment Market, Revenues & Volume, By Drug, 2021 - 2031 |
7.5 North America Bursitis Treatment Market, Revenues & Volume, By Delivery Type, 2021 - 2031 |
7.6 North America Bursitis Treatment Market, Revenues & Volume, By End Use, 2021 - 2031 |
8 Latin America (LATAM) Bursitis Treatment Market, Overview & Analysis |
8.1 Latin America (LATAM) Bursitis Treatment Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Bursitis Treatment Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Bursitis Treatment Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Bursitis Treatment Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Bursitis Treatment Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Bursitis Treatment Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Bursitis Treatment Market, Revenues & Volume, By Devices, 2021 - 2031 |
8.4 Latin America (LATAM) Bursitis Treatment Market, Revenues & Volume, By Drug, 2021 - 2031 |
8.5 Latin America (LATAM) Bursitis Treatment Market, Revenues & Volume, By Delivery Type, 2021 - 2031 |
8.6 Latin America (LATAM) Bursitis Treatment Market, Revenues & Volume, By End Use, 2021 - 2031 |
9 Asia Bursitis Treatment Market, Overview & Analysis |
9.1 Asia Bursitis Treatment Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Bursitis Treatment Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Bursitis Treatment Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Bursitis Treatment Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Bursitis Treatment Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Bursitis Treatment Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Bursitis Treatment Market, Revenues & Volume, By Devices, 2021 - 2031 |
9.4 Asia Bursitis Treatment Market, Revenues & Volume, By Drug, 2021 - 2031 |
9.5 Asia Bursitis Treatment Market, Revenues & Volume, By Delivery Type, 2021 - 2031 |
9.6 Asia Bursitis Treatment Market, Revenues & Volume, By End Use, 2021 - 2031 |
10 Africa Bursitis Treatment Market, Overview & Analysis |
10.1 Africa Bursitis Treatment Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Bursitis Treatment Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Bursitis Treatment Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Bursitis Treatment Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Bursitis Treatment Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Bursitis Treatment Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Bursitis Treatment Market, Revenues & Volume, By Devices, 2021 - 2031 |
10.4 Africa Bursitis Treatment Market, Revenues & Volume, By Drug, 2021 - 2031 |
10.5 Africa Bursitis Treatment Market, Revenues & Volume, By Delivery Type, 2021 - 2031 |
10.6 Africa Bursitis Treatment Market, Revenues & Volume, By End Use, 2021 - 2031 |
11 Europe Bursitis Treatment Market, Overview & Analysis |
11.1 Europe Bursitis Treatment Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Bursitis Treatment Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Bursitis Treatment Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Bursitis Treatment Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Bursitis Treatment Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Bursitis Treatment Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Bursitis Treatment Market, Revenues & Volume, By Devices, 2021 - 2031 |
11.4 Europe Bursitis Treatment Market, Revenues & Volume, By Drug, 2021 - 2031 |
11.5 Europe Bursitis Treatment Market, Revenues & Volume, By Delivery Type, 2021 - 2031 |
11.6 Europe Bursitis Treatment Market, Revenues & Volume, By End Use, 2021 - 2031 |
12 Middle East Bursitis Treatment Market, Overview & Analysis |
12.1 Middle East Bursitis Treatment Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Bursitis Treatment Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Bursitis Treatment Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Bursitis Treatment Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Bursitis Treatment Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Bursitis Treatment Market, Revenues & Volume, By Devices, 2021 - 2031 |
12.4 Middle East Bursitis Treatment Market, Revenues & Volume, By Drug, 2021 - 2031 |
12.5 Middle East Bursitis Treatment Market, Revenues & Volume, By Delivery Type, 2021 - 2031 |
12.6 Middle East Bursitis Treatment Market, Revenues & Volume, By End Use, 2021 - 2031 |
13 Global Bursitis Treatment Market Key Performance Indicators |
14 Global Bursitis Treatment Market - Export/Import By Countries Assessment |
15 Global Bursitis Treatment Market - Opportunity Assessment |
15.1 Global Bursitis Treatment Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Bursitis Treatment Market Opportunity Assessment, By Devices, 2021 & 2031F |
15.3 Global Bursitis Treatment Market Opportunity Assessment, By Drug, 2021 & 2031F |
15.4 Global Bursitis Treatment Market Opportunity Assessment, By Delivery Type, 2021 & 2031F |
15.5 Global Bursitis Treatment Market Opportunity Assessment, By End Use, 2021 & 2031F |
16 Global Bursitis Treatment Market - Competitive Landscape |
16.1 Global Bursitis Treatment Market Revenue Share, By Companies, 2024 |
16.2 Global Bursitis Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here